Expression and distribution of glucocorticoid receptor isoforms in eosinophilic chronic rhinosinusitis

Auris Nasus Larynx

Volumn 37, Issue 6, 2010, Pages 700-707

  Takeda, Kazumasa ^a   Takeno, Sachio ^a   Hirakawa, Katsuhiro ^a   Ishino, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Eosinophilic chronic rhinosinusitis (ECRS); Eosinophilic infiltration; Fluorescence immunohistochemistry; Glucocorticoid receptor isoforms; Paranasal sinus mucosa; Steroid insensitivity

Indexed keywords

GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; MESSENGER RNA;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC SINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SINUS SURGERY; EOSINOPHILIA; ETHMOID SINUS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MALE; MAXILLARY SINUS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; TISSUE DISTRIBUTION;

ADULT; CHRONIC DISEASE; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PARANASAL SINUSES; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS; RNA, MESSENGER; SINUSITIS; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 77955508874     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2010.03.005     Document Type: Article

References (37)

1. Haruna S., Otori N., Moriyama H. Olfactory dysfunction in sinusitis with infiltration of numerous activated eosinophils. Auris Nasus Larynx 2006, 33:23-30.
2. Kennedy D.W. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992, 102(Suppl. 57):1-18.
3. Alobid I., Benítez P., Bernal-Sprekelsen M., Roca J., Alonso J., Picado C., et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005, 60:452-458.
4. Jankowski R., Klossek J.M., Attali V., Roca J., Alonso J., Picado C., et al. Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis. Allergy 2009, 64:944-950.
5. Lund V.J., Flood J., Sykes A.P., Richards D.H. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998, 124:513-518.
6. Mastruzzo C., Greco L.R., Nakano K., Nakano A., Palermo F., Pistorio M.P., et al. Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation. J Allergy Clin Immunol 2003, 112:37-44.
7. Mastalerz L., Milewski M., Duplaga M., Nizankowska E., Szczeklik A. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 1997, 52:895-900.
8. Keith P., Nieminen J., Hollingworth K., Dolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400mg once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000, 30:1460-1468.
9. Pujols L., Mullol J., Benítez P., Torrego A., Xaubet A., de Haro J., et al. Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 2003, 97:90-96.
10. Hamilos D.L., Leung D.Y.M., Muro S., Kahn A.M., Hamilos S.S., Thawley S.E., et al. GRβ expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001, 108:59-68.
11. Christodoulopoulos P., Leung D.Y., Elliott M.W., Hogg J.C., Muro S., Toda M., et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000, 106:479-484.
12. Hamilos D.L., Leung D.Y., Muro S., Kahn A.M., Hamilos S.S., Thawley S.E., et al. GRbeta expression in nasal polyps inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001, 108:59-68.
13. Kraft M., Hamid Q., Chrousos G.P., Martin R.J., Leung D.Y. Decreased steroid responsiveness at night in nocturnal asthma. Is the macrophage responsible?. Am J Respir Crit Care Med 2001, 163:1219-1225.
14. Practical Guideline for the Management of Allergic Rhinitis in Japan (PG-MARJ) 2009, Life Science, Tokyo, Japan, p. 18-31. 6th ed. M. Okuda, K. Baba, A. Konno, H. Takenaka (Eds.).
15. Lund V.J., Kennedy D.W. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1998, 117:S35-S40.
16. Takeno S., Hirakawa K., Ueda T., Furukido K., Osada R., Yajin K. Nuclear factor-kappa B activation in the nasal polyp epithelium: relationship to local cytokine gene expression. Laryngoscope 2002, 112:53-58.
17. van den Berg A, Visser L., Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999, 154:1685-1691.
18. Towers R., Naftali T., Gabay G., Carlebach M., Klein A., Novis B. High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. Clin Exp Immunol 2005, 141:357-362.
19. Takeno S., Yajin K., Hisayuki A., Furukido K., Hirakawa K., Ishino T., et al. Comparison of local cytokine gene expression and the distribution of eosinophils and CD4-positive cell subsets in the paranasal sinus mucosa between atopic and non-atopic subjects. Allergol Int 2004, 53:135-144.
20. Newman L.J., Platts-Mills T.A., Phillips C.D., Hazen K.C., Gross C.W. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 1994, 271:363-367.
21. Szucs E., Ravandi S., Goossens A., Beel M., Clement P.A. Eosinophilia in the ethmoid mucosa and its relationship to the severity of inflammation in chronic rhinosinusitis. Am J Rhinol 2002, 16:131-134.
22. Ferguson B.J. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000, 110:799-813.
23. Takaki M., Ushikai M., Deguchi K., Nishimoto K., Matsune S., Kurono Y. The role of nuclear factor-kappa B in interleukin-8 expression by human adenoidal fibroblasts. Laryngoscope 2003, 113:1378-1385.
24. Wallwork B., Coman W., Mackay-Sim A., Cervin A. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope 2004, 114:286-290.
25. Poznanovic S.A., Kingdom T.T. Total IgE levels and peripheral eosinophilia correlation with mucosal disease based on computed tomographic imaging of the paranasal sinus. Arch Otolaryngol Head Neck Surg 2007, 133:701-704.
26. Göttlicher M., Heck S., Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998, 76:480-489.
27. Gonzalez M.V., Jimenez B., Berciano M.T., González-Sancho J.M., Caelles C., Lafarga M., et al. Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution. J Cell Biol 2000, 150:1199-1208.
28. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994, 91:752-756.
29. Brogan I.J., Murray I.A., Cerillo G., Needham M., White A., Davis J.R. Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kappa B: lack of effect of glucocorticoid receptor beta. Mol Cell Endocrinol 1999, 157:95-104.
30. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor β isoform specificity and mechanisms of action. J Biol Chem 1999, 274:27857-27866.
31. Webster J.C., Oakley R.H., Jewell C.M., Cidlowski J.A. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001, 98:6865-6870.
32. Hecht K., Carlstedt-Duke J., Stierna P., Gustafsson J., Brönnegârd M., Wikström A.C. Evidence that the β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 1997, 272:26659-26664.
33. Pujols L., Mullol J., Roca-Ferrer J., Torrego A., Xaubet A., Cidlowski J.A., et al. Expression of glucocorticoid receptor α and β-isoforms in human cells and tissues. Am J Physiol Cell Physiol 2002, 283:C1324-C1331.
34. Strickland I., Kisich K., Hauk P.J., Vottero A., Chrousos G.P., Klemm D.J., et al. High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001, 193:585-593.
35. Orii F., Ashida T., Nomura M., Maemoto A., Fujiki T., Ayabe T., et al. Quantitative analysis for human glucocorticoid receptor α/β mRNA in IBD. Biochem Biophys Res Commun 2002, 296:1286-1294.
36. Leung D.Y., Szefler S.J. Diagnosis and management of steroid-resistant asthma. Clin Chest Med 1997, 18:611-625.
37. Valera F.C., Queiroz R., Scrideli C., Tone L.G., Anselmo-Lima W.T. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clin Exp Allergy 2009, 39:81-88.